Literature DB >> 20193462

[Guidelines for HER2 detection in breast cancer, the 2009 version].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20193462

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN： 0529-5807


× No keyword cloud information.
  2 in total

1.  ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients.

Authors:  Liying Guo; Y U Zhang; Dilimina Yilamu; Sha Liu; Chenming Guo
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

2.  Expression of ERβ, ERα and Her-2 and distribution of molecular subtypes in Uygur and Han patients with breast cancer.

Authors:  Liying Guo; Xueqin Hou; Yilamu Dilimina; Bowei Wang
Journal:  Exp Ther Med       Date:  2014-03-04       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.